GU Cancers 2020 | Bladder: Adjuvant chemotherapy and I-O

Name: Bladder: Adjuvant chemotherapy and I-O
Uploaded: 2020-02-15T10:00:09Z
Description: Nicholas James, MBBS, PhD, FRCP, FRCR, The Institute of Cancer Research, London, UK, shares his highlights from a session on practising beyond clinical trial data in urothelial cancer. Specifically, he discusses adjuvant chemotherapy and immuno-oncology. This interview was recorded at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.

Nicholas James • 15 Feb 2020

GU Cancers 2020

Bladder Cancer Genitourinary Cancer

Nicholas James, MBBS, PhD, FRCP, FRCR, The Institute of Cancer Research, London, UK, shares his highlights from a session on practising beyond clinical trial data in urothelial cancer. Specifically, he discusses adjuvant chemotherapy and immuno-oncology. This interview was recorded at the 2020 Genitourinary Cancers Symposium, held in San Francisco, CA.